Sangamo Therapeutics
SGMO
#10568
Rank
โ‚น2.93 B
Marketcap
โ‚น7.08
Share price
0.00%
Change (1 day)
-86.21%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -โ‚น9.92 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น34.55 Million. In 2025 the company made an earning of -โ‚น10.35 Billion a decrease over its 2024 earnings that were of -โ‚น9.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น9.92 Billion-4.1%
2025 -โ‚น10.35 Billion9.71%
2024 -โ‚น9.43 Billion-17.27%
2023 -โ‚น11.4 Billion-40.88%
2022 -โ‚น19.28 Billion9.79%
2021 -โ‚น17.56 Billion41.52%
2020 -โ‚น12.41 Billion23.17%
2019 -โ‚น10.07 Billion36.33%
2018 -โ‚น7.39 Billion36.89%
2017 -โ‚น5.4 Billion-22.32%
2016 -โ‚น6.95 Billion54.86%
2015 -โ‚น4.49 Billion75.62%
2014 -โ‚น2.56 Billion0.13%
2013 -โ‚น2.56 Billion
2011 -โ‚น3.43 Billion43.66%
2010 -โ‚น2.39 Billion28.52%
2009 -โ‚น1.86 Billion-23.55%
2008 -โ‚น2.43 Billion2.45%
2007 -โ‚น2.38 Billion19.5%
2006 -โ‚น1.99 Billion50.78%
2005 -โ‚น1.32 Billion75%
2004 -โ‚น0.76 Billion-33.25%
2003 -โ‚น1.13 Billion-62.27%
2002 -โ‚น2.99 Billion102.82%
2001 -โ‚น1.48 Billion23.21%
2000 -โ‚น1.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.487 T-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น869.98 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น155.38 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น241.94 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.027 T-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.259 T-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น83.26 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.91 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA